Table of Contents
2019-2024 Global Rufinamide Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rufinamide Market Size 2014-2024
2.1.2 Rufinamide Market Size CAGR by Region
2.2 Rufinamide Segment by Type
2.2.1 Tablets
2.2.2 Oral suspension
2.3 Rufinamide Market Size by Type
2.3.1 Global Rufinamide Market Size Market Share by Type (2014-2019)
2.3.2 Global Rufinamide Market Size Growth Rate by Type (2014-2019)
2.4 Rufinamide Segment by Application
2.4.1 Adults
2.4.2 Pediatric patients
2.5 Rufinamide Market Size by Application
2.5.1 Global Rufinamide Market Size Market Share by Application (2014-2019)
2.5.2 Global Rufinamide Market Size Growth Rate by Application (2014-2019)
3 Global Rufinamide by Players
3.1 Global Rufinamide Market Size Market Share by Players
3.1.1 Global Rufinamide Market Size by Players (2017-2019)
3.1.2 Global Rufinamide Market Size Market Share by Players (2017-2019)
3.2 Global Rufinamide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Rufinamide by Regions
4.1 Rufinamide Market Size by Regions
4.2 Americas Rufinamide Market Size Growth
4.3 APAC Rufinamide Market Size Growth
4.4 Europe Rufinamide Market Size Growth
4.5 Middle East & Africa Rufinamide Market Size Growth
5 Americas
5.1 Americas Rufinamide Market Size by Countries
5.2 Americas Rufinamide Market Size by Type
5.3 Americas Rufinamide Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Rufinamide Market Size by Countries
6.2 APAC Rufinamide Market Size by Type
6.3 APAC Rufinamide Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Rufinamide by Countries
7.2 Europe Rufinamide Market Size by Type
7.3 Europe Rufinamide Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Rufinamide by Countries
8.2 Middle East & Africa Rufinamide Market Size by Type
8.3 Middle East & Africa Rufinamide Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Rufinamide Market Forecast
10.1 Global Rufinamide Market Size Forecast (2019-2024)
10.2 Global Rufinamide Forecast by Regions
10.2.1 Global Rufinamide Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Rufinamide Forecast by Type
10.8 Global Rufinamide Forecast by Application
11 Key Players Analysis
11.1 Eisai
11.1.1 Company Details
11.1.2 Rufinamide Product Offered
11.1.3 Eisai Rufinamide Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Eisai News
11.2 Glenmark Pharms
11.2.1 Company Details
11.2.2 Rufinamide Product Offered
11.2.3 Glenmark Pharms Rufinamide Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Glenmark Pharms News
11.3 Mylan
11.3.1 Company Details
11.3.2 Rufinamide Product Offered
11.3.3 Mylan Rufinamide Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Mylan News
11.4 West-ward Pharms
11.4.1 Company Details
11.4.2 Rufinamide Product Offered
11.4.3 West-ward Pharms Rufinamide Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 West-ward Pharms News
...
12 Research Findings and Conclusion
